Effects of alterations in the metabolism of gamma-aminobutyrate on convulsant potencies.
D015097:3-Mercaptopropionic Acid; D000613:Aminobutyrates / Q000378:metabolism*; D000625:Aminooxyacetic Acid / Q000494:pharmacology; D000818:Animals; D001640:Bicuculline; D003931:Diacetyl / Q000494:pharmacology; D004357:Drug Synergism; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology; D008297:Male; D051379:Mice; D010433:Pentylenetetrazole; D010624:Phenelzine / Q000494:pharmacology; D010852:Picrotoxin; D011736:Pyridoxine / Q000031:analogs & derivatives / Q000494:pharmacology; D011930:Reaction Time; D012640:Seizures / Q000139:chemically induced / Q000378:metabolism*; D013871:Thiones / Q000494:pharmacology; D014635:Valproic Acid / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D015097:3-Mercaptopropionic Acid; D000613:Aminobutyrates; D000625:Aminooxyacetic Acid; D001640:Bicuculline; D003931:Diacetyl; D005998:Glycine; D006834:Hydrazines; D010433:Pentylenetetrazole; D010624:Phenelzine; D010852:Picrotoxin; D011736:Pyridoxine; D013871:Thiones; D014635:Valproic Acid; D005680:gamma-Aminobutyric Acid